[Progress in the field of drug development. 4].
D000661:Amphetamine; D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000932:Antiemetics; D000935:Antifungal Agents; D000978:Antiparkinson Agents; D000998:Antiviral Agents; D001067:Appetite Depressants; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors; D055598:Chemical Phenomena; D002621:Chemistry; D003276:Contraceptives, Oral; D004202:Disinfectants; D004358:Drug Therapy; D004967:Estrogens; D005260:Female; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D006801:Humans; D008297:Male; D011453:Prostaglandins; D012702:Serotonin Antagonists; D013963:Thyroid Hormones; D014149:Tranquilizing Agents
D000871:Anthelmintics; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D000932:Antiemetics; D000935:Antifungal Agents; D000978:Antiparkinson Agents; D000998:Antiviral Agents; D001067:Appetite Depressants; D003276:Contraceptives, Oral; D004202:Disinfectants; D004967:Estrogens; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D011453:Prostaglandins; D012702:Serotonin Antagonists; D013963:Thyroid Hormones; D014149:Tranquilizing Agents; D000661:Amphetamine; D002262:Carboxy-Lyases
Fortschritte auf dem Gebiet der Arzneimittelentwicklung. 4.